Los Angeles Business Journal

LA HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

NantHealth Unveils First Product of BlackBerry Collaboration

NantHealth, the health care technology division of billionaire Patrick Soon-Shiong’s Culver City holding company NantWorks, has revealed the first product of its collaboration with smartphone-maker BlackBerry: a secure clinical genome browser that gives doctors access to patients’ genetic data on the BlackBerry Passport smartphone.

Poll: Do you think vaping should be banned from public spaces?

Every week the Los Angeles Business Journal asks readers their views on a variety of business and economic issues. A running tally is available on the site and later will be published in the Commentary section of our print edition. Our latest poll is available on the bottom right column of our home page.

Montebello Man Sentenced to Three Years for Medicare Fraud

A physician’s assistant was sentenced Monday to three years in federal prison for defrauding Medicare out of millions of dollars by signing fraudulent prescriptions and other medical documents while working at two separate medical clinics in the Los Angeles area.

Amgen Halts Cancer Drug Trials After Deaths

Amgen Inc. announced on Monday it has ended two clinical studies on an experimental cancer drug after a preliminary review showed increased deaths among one group of patients.

Second Sight Soars in Market Debut

Shares of Second Sight Medical Products Inc. – the latest Alfred Mann company to go public – more than doubled Wednesday in its initial public offering.

CytRx Plunges: FDA Halts Trials After Patient Death

CytRx Corp. shares fell 9 percent Tuesday after the company announced the U.S. Food and Drug Administration had placed a hold on enrolling new patients in clinical trials of its experimental cancer drug following the death of a patient.

Second Sight Delays IPO

Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, delayed its planned $30 million IPO until Wednesday.

Second Sight's $30 Million IPO Set For Tuesday

Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, plans to launch a $30 million initial public offering on Tuesday.

MannKind Narrows Loss

MannKind Corp. posted narrow third-quarter losses on Monday as the company winds down its research operations and prepares to start selling its Afrezza brand inhalable insulin.

Two Indicted in Alleged L.A. Medicare Scheme

An owner of Los Angeles home health agency Fifth Avenue Home Health has been indicted for allegedly aiding in a $33 million scheme to defraud Medicare, the U.S. Justice Department announced Thursday.

Amgen Cuts Costs, Beats Estimates

Amgen posted third-quarter earnings Monday that beat Wall Street estimates, as the company reported strong drug sales and benefited from cost-cutting once restructuring costs were excluded.

Expanding USC Partners With Clinic Operator

USC’s medical system announced on Wednesday that it will partner with Surgical Care Affiliates Inc. to jointly manage surgery centers in the Los Angeles region, starting with one in Glendale.

Loeb Ups Stake in Amgen, Calls for Breakup

Shares of Amgen Inc. jumped nearly 5 percent Tuesday on heavy volume after billionaire hedge fund manager Dan Loeb disclosed he had upped his stake in the company and called for its breakup.

Amgen, Gates Foundation to Develop Ebola Treatment

Amgen Inc. is teaming with the Bill & Melinda Gates Foundation to develop a faster production method for Zmapp, an experimental Ebola treatment, according to the company.

Wounded Veterans to Test NeuroSigma Device

Less than a week after postponing its initial public offering, West L.A. medical device maker NeuroSigma announced Wednesday that it has entered into a research and development agreement with U.S. Veterans Affairs for a clinical trial.